On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and sell the assay in Europe and in countries that accept the CE Mark, and authorization from Health Canada to sell the assay in Canada.

Also, the EUA was extended, allowing the assay to run on three additional thermocyclers: Applied Biosystems 7500 Standard, Roche LightCycler 480, and Qiagen Rotor-Gene Q. Additionally, the Centers for Disease Control and Prevention has expanded the list of acceptable specimens to include nasal and nasal turbinate swabs.